转移性非典型和间变性脑膜瘤:病例系列及文献综述
该研究回顾性分析了168例WHO II级和III级脑膜瘤患者,其中6例经组织学确诊为转移性病变。文章讨论了这6例患者转移至肺、肝和脊柱的临床、影像和病理过程,并综述相关文献,评估辅助化疗药物的临床获益。
要点
- 非典型和间变性脑膜瘤占所有脑膜瘤不足5%,颅外转移仅占全部病例的0.1%。
- 168例WHO II级和III级脑膜瘤患者中,6例经组织学确诊为转移性疾病。
- 转移部位包括肺、肝和脊柱,文章讨论了其临床、影像和病理过程。
核心结论
- 文章讨论了6例非典型或间变性脑膜瘤转移患者的临床过程,并综述文献评估辅助化疗药物的临床获益。
研究设计与样本
- 对168例诊断为WHO II级和III级脑膜瘤的患者进行回顾性病历复习,其中6例经组织学确诊为转移性疾病。
主要发现
- 在168例WHO II级和III级脑膜瘤患者中,6例经组织学确诊为转移性疾病,转移部位包括肺、肝和脊柱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atypical (World Health Organization grade II) and anaplastic (World Health Organization grade III) meningiomas are rare, accounting for less than 5% of all meningiomas. Histologic grading has a significant impact on prognosis, risk of recurrence, and the need for adjuvant radiation or chemotherapy. Extracranial metastases are even more infrequent and occur in 0.1% of all cases. METHODS: Retrospective chart review of 168 patients with diagnosis of WHO grade II and III meningiomas was performed. Six patients with histologically confirmed metastatic disease were identified. RESULTS: We discuss the clinical, radiologic, and histopathologic clinical course of 6 patients with metastasis to the lung, liver, and spine from all patients with atypical or anaplastic meningioma treated at Johns Hopkins Hospital from 1993 to 2014. CONCLUSIONS: We reviewed the literature pertaining to this phenomenon and subsequently assessed the clinical benefits of adjuvant chemotherapeutic agents in patients with meningioma with metastatic disease.
引用
- Kessler RA, Garzon-Muvdi T, Yang W, et al. Metastatic Atypical and Anaplastic Meningioma: A Case Series and Review of the Literature. World Neurosurg. 2017. PMID: 28143726. doi:10.1016/j.wneu.2017.01.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。